Clinical analysis of EV‐Fingerprint to predict grade group 3 and above prostate cancer and avoid prostate biopsy

BACKGROUND: There is an unmet clinical need for minimally invasive diagnostic tests to improve the detection of grade group (GG) ≥3 prostate cancer relative to prostate antigen‐specific risk calculators. We determined the accuracy of the blood‐based extracellular vesicle (EV) biomarker assay (EV Fin...

Descripción completa

Detalles Bibliográficos
Autores principales: Fairey, Adrian, Paproski, Robert J., Pink, Desmond, Sosnowski, Deborah L., Vasquez, Catalina, Donnelly, Bryan, Hyndman, Eric, Aprikian, Armen, Kinnaird, Adam, Beatty, Perrin H., Lewis, John D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469644/
https://www.ncbi.nlm.nih.gov/pubmed/37329212
http://dx.doi.org/10.1002/cam4.6216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469644/
https://www.ncbi.nlm.nih.gov/pubmed/37329212
http://dx.doi.org/10.1002/cam4.6216

Ejemplares similares